Short Arrestin-3-Derived Peptides Activate JNK3 in Cells

Area of Science:

• Molecular Biology
• Cell Signaling

Background:

• Arrestins, initially known as G protein-coupled receptor signaling suppressors, also initiate signaling pathways like mitogen-activated protein kinase (MAPK) cascades.
• Arrestin-3's role in activating the JNK (c-Jun N-terminal kinase) family can be mimicked by specific peptide fragments.

Purpose of the Study:

• To identify specific arrestin-3 peptide elements that bind to and activate kinases within the ASK1-MKK4/7-JNK3 signaling cascade.
• To determine the shortest peptide sequence capable of facilitating JNK signaling.

Main Methods:

• Utilized maltose-binding protein fusions of arrestin-3-derived peptides to investigate kinase interactions.
• Employed Venus fusion proteins to express and test the activity of identified arrestin-3 peptides in cellular models.

Main Results:

• Identified a 16-residue arrestin-3 peptide that successfully activates JNK3α2 in cells.
• Demonstrated that the binding affinity of the peptide to kinases does not directly correlate with its JNK signaling activation potency.
• The ASK1-MKK4/7-JNK3 cascade, implicated in neuronal apoptosis, was targeted.

Conclusions:

• Short arrestin-3-derived peptides can function as potent activators of the JNK3 kinase.
• These peptides represent the first small molecule tools capable of activating MAP kinases, distinct from existing inhibitors.
• This research opens avenues for developing novel therapeutic strategies targeting MAPK pathways in conditions like neuronal apoptosis.